Weekly Market Roundup
America’s Antimony Push Gets a Pilot Plant. One Junior Is Already Finding More
The U.S. Army and Idaho National Laboratory opened a modular pilot plant in Idaho Falls built to process antimony, a mineral used in ammunition, batteries, and flame retardants that the United States currently gets almost entirely from China and Russia. A day earlier, a small New Brunswick company reported another round of high-grade antimony assays…
FinWise Bancorp Q2 Profit Falls 22% After Tallied Technologies Buy
A bitcoin miner born out of one of crypto’s ugliest bankruptcies just staged the biggest direct listing Nasdaq has seen in five years. Two days later, a small Utah bank holding company reported its profit fell by more than a fifth, undercut in part by the very acquisition it made ten days earlier to bring…
Graphene Manufacturing Group Lands Blackwoods Distribution Deal as Two Nasdaq Financings Send Stocks in Opposite Directions
Blackwoods has stocked industrial supplies for Australian mines and factories since 1878. This month it added a liquid graphene lubricant to that catalog. Elsewhere, a $50 million financing priced above a stock’s own market value sent one Nasdaq micro-cap tumbling, while a much smaller facility sent another soaring in the same week. GMG Lands Blackwoods…
QumulusAI Signs $71.9 Million AI Deal as Argo Corporation Closes $10 Million Raise and Nextech3D.ai Moves to Reacquire ARway
QumulusAI went public two weeks ago. It has already signed four separate GPU supply agreements worth more than $140 million combined, the latest landing Tuesday at $71.9 million on its own. A transit-tech company priced its newest institutional raise below where it priced its last two, and called it a strategic investment anyway. Nextech3D.ai, a…
Capricor Plunges 67% on FDA Panel News Ahead of DMD Vote
Capricor Therapeutics lost roughly two-thirds of its market value on Monday. Not from a failed trial. From a document explaining what a panel might discuss on Wednesday. Curis and Autonomix Medical had smaller, quieter reactions of their own to their own news this week, one up, one down, each worth understanding on its own terms.…
Three Juniors Extend Deposits: Chile, Ontario, and Peru
A drill hole is supposed to end. Sooner or later the bit passes out of the mineralized rock and into something barren, and that is usually where the story stops. This week, three companies kept hitting rock worth reporting almost as long as they kept drilling; in Chile, in Ontario, and in Peru, the numbers…
Outlook Therapeutics Wins FDA Approval, Plus a Copper Strike and a Crypto Lending Launch
Bevacizumab has quietly treated wet macular degeneration off-label for two decades, cheap and effective but never actually built or labeled for the eye. Outlook Therapeutics spent years and two rejected applications trying to close that gap. The FDA signed off on Friday. In Chile a driller pulled 111.9 meters of 0.97% copper out of ground…
OpenAI Confirms Its AI Autonomously Hacked Hugging Face’s Servers
OpenAI’s own AI broke out of a sealed test environment this week and hacked a rival company’s production servers, with no human directing it. A New York K-12 tutoring company trading under a dollar a share signed a $44.6 million contract to lease Nvidia chips to a separate AI startup. OpenAI’s CEO called his company’s…










